Best MEDVi Alternatives for Lower Long-Term GLP-1 Costs in 2026

Last reviewed: September 7, 2026 Last updated: September 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

The short answer

MEDVi charges an introductory rate of $179 for the first month of compounded semaglutide injection, then $299 per month for refills; tirzepatide starts at an introductory rate of $279 and refills at $399 per month (prices captured September 4, 2026). Over twelve months of month-to-month service, MEDVi costs $3,468 for semaglutide ($289 average per month) and $4,668 for tirzepatide ($389 average per month), calculated by summing the first-month introductory rate and eleven refills at the standard ongoing rate.

Several alternatives publish lower ongoing rates with no introductory step-up. PlexusDx charges $189 per month for compounded semaglutide injection month-to-month (3-month commitment: $169/month; 6-month commitment: $149/month) and $289 per month for compounded tirzepatide injection month-to-month (3-month: $269/month; 6-month: $249/month). Over twelve months at standard ongoing refill rates—removing MEDVi's first-month discount and comparing refill-to-refill—PlexusDx month-to-month pricing saves $1,320 per year ($110 per month) on both semaglutide and tirzepatide versus MEDVi's published refill prices.

The decision hinges on whether you value MEDVi's included care coaching, free dietitian visit, and unlimited doctor calls enough to offset the higher medication cost, or whether you prefer transparent flat-rate pricing that rewards longer commitment with no prepaid bundle required.

At-a-glance pricing comparison: MEDVi vs PlexusDx

All figures captured September 4, 2026. MEDVi first-month rates are introductory; refill rates apply from month two onward. PlexusDx rates are flat ongoing month-to-month prices; 3-month and 6-month commitments reduce costs further. Twelve-month totals are our calculation.

Breaking down the long-term cost: intro rates versus flat refill pricing

MEDVi's pricing structure separates the first month from all subsequent refills. For semaglutide injection, the introductory first-month rate is $179, then $299 per month thereafter. Over twelve months, that yields $179 + ($299 × 11) = $3,468 total, or an average of $289 per month when the discount is blended across the year. For tirzepatide, the introductory first-month rate is $279 and refills run $399, totaling $4,668 over twelve months ($389 average per month).

PlexusDx publishes a single flat rate for each medication and commitment tier. Month-to-month semaglutide injection is $189 every month with no step-up; twelve months costs $2,268 total. Tirzepatide injection is $289 per month month-to-month, or $3,468 over twelve months. Committing to three months drops semaglutide to $169 per month ($2,028 annually, prepaid per-month equivalent) and tirzepatide to $269 per month ($3,228 annually, prepaid per-month equivalent); a six-month commitment brings semaglutide to $149 per month ($1,788 annually, prepaid per-month equivalent) and tirzepatide to $249 per month ($2,988 annually, prepaid per-month equivalent). All PlexusDx commitment prices are our calculation of the per-month equivalent; the total is paid across the commitment period, and all rates remain the same regardless of dose escalation.

If you compare ongoing refill rates only—removing MEDVi's first-month discount—PlexusDx saves $110 per month on semaglutide ($299 vs. $189) and $110 per month on tirzepatide ($399 vs. $289). Over a full year at those standard ongoing rates, the savings total $1,320. Even with MEDVi's introductory discount blended into year one, PlexusDx month-to-month semaglutide saves $1,200 in the first twelve months ($3,468 vs. $2,268), and tirzepatide saves the same $1,200 ($4,668 vs. $3,468).

MEDVi's longer prepaid ladder and financing option

MEDVi offers three-, six-, and twelve-month prepaid bundles with pricing that is not publicly disclosed on the homepage but available at checkout (captured July 20, 2026). These bundles are non-refundable for unused months, and MEDVi extends commitment terms up to 48 weeks. The service also advertises 0% financing through Klarna spread over twelve months; MEDVi states it is not a party to the Klarna credit agreement, which is a separate contract between the patient and the lender.

PlexusDx publishes all commitment-tier pricing before intake begins: $169 per month at three-month commitment and $149 per month at six-month commitment for semaglutide injection (prepaid per-month equivalents, our calculation), with corresponding reductions for tirzepatide. These commitments do not require full prepayment; the patient pays monthly at the discounted rate. No financing arrangement is offered because no large upfront sum is collected.

If you have cash flow to commit and want the structure of a longer prepaid term, MEDVi's bundle ladder may suit you. If you prefer to see the per-month savings without bundling, PlexusDx's published commitment discounts deliver a lower effective rate with monthly billing.

Included support: care coaching and dietitian visits versus pharmacist check-ins

MEDVi includes free care coaching, a free dietitian visit, and unlimited doctor calls in every subscription at no additional membership fee. These services are embedded in the medication price. For patients who value structured behavioral support and routine clinician access beyond prescription management, this represents meaningful added value that partially offsets the higher medication cost.

PlexusDx includes a free check-in with a Doctor of Pharmacy and charges no membership fee. Clinical oversight is provided through the prescribing licensed healthcare provider, and ongoing questions are handled through the platform. An optional genetic testing add-on is available for $99 to program members (regular $298); the test does not select or predict which medication will work, and a licensed clinician determines whether a prescription is appropriate for each individual patient.

If behavioral coaching and scheduled dietitian consultations are central to your plan, MEDVi's included services may justify the higher refill rate. If you prefer pharmacist-led medication guidance and want the lowest sustainable cost, PlexusDx's model separates clinical support from optional add-ons and prices the medication itself lower.

Oral options and dose-increase policies

MEDVi offers compounded semaglutide tablets (oral route) at a $70 surcharge over injection: introductory first-month rate $249, refills $369 per month. PlexusDx offers oral semaglutide at $289 per month month-to-month, $269 at three-month commitment (prepaid per-month equivalent, our calculation), and $249 at six-month commitment (prepaid per-month equivalent, our calculation). Both providers hold dose increases at the same subscription price; escalating from lower to higher milligram strengths does not trigger a price change.

For patients who prefer to avoid injections entirely, PlexusDx's oral semaglutide at $289 month-to-month is $80 per month less than MEDVi's $369 refill rate for tablets. At a six-month commitment, PlexusDx's oral semaglutide drops to $249 per month (prepaid per-month equivalent, our calculation), a $120 monthly saving versus MEDVi's ongoing oral rate.

Review record and reported service quality

MEDVi holds a 4.3-star rating on Trustpilot across approximately 15,000 reviews (captured September 2026). The majority of reviews are positive, citing responsive customer support and smooth onboarding. A smaller volume of critical reviews on Trustpilot describes delayed shipments, difficulty reaching support during high-volume periods, and occasional billing confusion around the transition from introductory to refill pricing. These reports are individual customer allegations; we cannot verify their frequency or representativeness, and they should be considered anecdotes rather than established patterns.

PlexusDx holds a 4.3-star rating on Trustpilot, with 79 percent of reviews at five stars and 83 percent at four stars or higher (captured September 9, 2026). Positive themes emphasize transparent pricing, pharmacist accessibility, and straightforward medication delivery. Negative reviews cite occasional shipping delays and variable response times during intake.

Both services operate above the 4.0-star threshold that typically signals reliable performance, and both carry the inherent variability of any telehealth model relying on third-party compounding pharmacies and courier logistics. If you want to read current customer reports before deciding, check each provider's Trustpilot profile and filter for recent reviews matching your medication and route of administration.

Other alternatives captured in September 2026

Several other compounded GLP-1 providers were checkout-verified in September 2026 alongside MEDVi. Eden charges $199 per month for semaglutide injection month-to-month, with a three-month prepaid option at an introductory rate of $179 per month ($537 upfront, standard ongoing refill rate not separately disclosed). Embody lists semaglutide at $249 per month. Found bundles medication with a $99 per month membership; semaglutide injection adds $149 per month, making the effective total $248 per month. Henry Meds offers semaglutide injection at $297 per month. Peak Wellness charges $299 per month for semaglutide. TrimRx lists semaglutide at $249 per month month-to-month.

Among this cohort, PlexusDx at $189 per month for semaglutide injection month-to-month and $289 per month for tirzepatide injection month-to-month delivers the lowest standard month-to-month rate, with commitment discounts further reducing effective cost. Eden's three-month prepaid option (introductory rate $179 per month, $537 upfront) undercuts PlexusDx's month-to-month rate by $10 but requires $537 upfront; PlexusDx's three-month commitment at $169 per month (prepaid per-month equivalent, our calculation) is $10 per month less than Eden's prepaid tier and is billed monthly rather than in a lump sum.

Choose MEDVi if…

MEDVi fits best when you want integrated behavioral support—free care coaching, a free dietitian visit, and unlimited doctor calls—bundled into the medication subscription without a separate membership fee. If you respond well to structured check-ins and anticipate needing frequent clinician access, MEDVi's included services may justify the higher refill rate of $299 for semaglutide and $399 for tirzepatide.

MEDVi also suits patients who prefer to lock in pricing through a prepaid bundle and spread the upfront cost with 0 percent financing via Klarna. If you have predictable cash flow and want the psychological commitment of a paid-in-advance plan extending up to 48 weeks, MEDVi's bundle ladder offers that structure.

Finally, if the introductory discount—$179 for semaglutide, $279 for tirzepatide—makes month one more accessible and you are uncertain about long-term use, MEDVi's lower entry price gives you a trial month before the refill rate takes effect.

Choose PlexusDx if…

PlexusDx makes sense when long-term cost is the dominant concern and you value pricing transparency. The published flat rates—$189 month-to-month for semaglutide injection, $149 at six-month commitment; $289 month-to-month for tirzepatide injection, $249 at six-month commitment (commitment rates are prepaid per-month equivalents, our calculation)—are lower than MEDVi's ongoing refill rates by $110 to $150 per month, depending on compound and commitment tier. Over a year, that gap totals $1,320 to $1,800 in savings (our calculation).

PlexusDx fits patients who prefer pharmacist-led medication guidance over behavioral coaching, and who do not require scheduled dietitian visits or unlimited doctor calls as part of the subscription. The free Doctor of Pharmacy check-in provides clinical medication oversight; behavioral and nutritional support are managed separately or outside the platform.

If you want the flexibility of month-to-month billing with an option to commit for a discount—but without prepaying a lump sum—PlexusDx's commitment tiers lower the per-month rate while preserving monthly invoicing. The service also publishes pricing for oral semaglutide ($289 month-to-month, $249 at six-month commitment, prepaid per-month equivalent, our calculation) at rates lower than MEDVi's $369 oral refill price, and offers a microdose GLP-1 maintenance option at $129 per month for patients stepping down from full therapeutic doses.

Methodology and freshness

All MEDVi pricing was captured via checkout verification on September 4, 2026, and cross-referenced against figures verified July 20, 2026. PlexusDx pricing reflects the published rate card as of September 2026. Twelve-month cost calculations and effective monthly rates are our calculation, derived by summing the first-month introductory rate and eleven refills for MEDVi, and multiplying the flat monthly rate by twelve for PlexusDx. Competitor pricing for Eden, Embody, Found, Henry Meds, Peak Wellness, and TrimRx was checkout-verified in September 2026.

Review data for MEDVi reflects Trustpilot's public profile captured in September 2026 (~15,000 reviews, 4.3-star average). PlexusDx review data was captured from Trustpilot on September 4, 2026 (4.3 stars, 79 percent five-star, 83 percent four stars or higher). Individual negative review themes are reported as customer allegations; we do not verify claim accuracy or representativeness and advise treating them as anecdotal reports rather than confirmed patterns.

This article does not guarantee eligibility, medication selection, dose, results, or side-effect outcomes.

Frequently Asked Questions

Does MEDVi's first-month discount make it cheaper than PlexusDx over one year?

No. MEDVi's semaglutide costs $3,468 over twelve months including the $179 introductory first-month rate; PlexusDx month-to-month semaglutide costs $2,268 over twelve months at a flat $189 rate, saving $1,200 in year one. For tirzepatide, MEDVi totals $4,668 including the introductory first month versus PlexusDx's $3,468, a $1,200 advantage for PlexusDx even with MEDVi's discount.

Are MEDVi's included coaching and dietitian visits worth the higher medication price?

That depends on how much you value structured behavioral support. MEDVi bundles free care coaching, a free dietitian visit, and unlimited doctor calls into the subscription; PlexusDx separates clinical oversight (free pharmacist check-in) from optional behavioral services. If you need frequent clinician contact and nutritional guidance, MEDVi's extras may justify paying $110 more per month.

Can I get PlexusDx's commitment discount without paying upfront?

Yes. PlexusDx's three-month and six-month commitments apply a discounted rate to each monthly invoice; you are not required to prepay the full term in a lump sum. MEDVi's prepaid bundles require upfront payment or financing, and are non-refundable for unused months.

Does PlexusDx offer oral semaglutide and how does it compare to MEDVi's tablets?

Yes. PlexusDx lists oral semaglutide at $289 per month month-to-month and $249 at six-month commitment (prepaid per-month equivalent, our calculation). MEDVi charges $369 per month for refills of compounded semaglutide tablets, making PlexusDx $80 to $120 per month less expensive for the oral route depending on commitment tier.

What happens to my cost in year two when MEDVi's intro pricing no longer applies?

Starting in month two and continuing through year two, MEDVi charges the standard refill rate: $299 per month for semaglutide and $399 per month for tirzepatide. PlexusDx remains $189 and $289 per month respectively on a month-to-month basis, or $149 and $249 at six-month commitment (prepaid per-month equivalents, our calculation), maintaining the $110 to $150 per month cost advantage throughout year two.

Sources

• MEDVi pricing and service details, checkout-verified September 4, 2026 and July 20, 2026
• PlexusDx pricing and program structure, published rate card accessed September 2026
• Eden, Embody, Found, Henry Meds, Peak Wellness, TrimRx pricing, checkout-verified September 2026
• MEDVi Trustpilot reviews, captured September 2026
• PlexusDx Trustpilot profile (4.3 stars, 79% five-star, 83% four stars or higher), captured September 9, 2026
• FDA guidance on compounded medications

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.